ArticleJournal of nephrology2024

Commentary on: The use of burosumab to treat autosomal-recessive hypophosphatemic rickets type 2: rationale and a first clinical experience.

Frank Rutsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.